Skip to content

Mindfulness-Music Intervention for Adolescents and Young Adults With Cancer

Exploring the Feasibility of a Mindfulness-Music Intervention to Reduce Anxiety and Stress in Adolescents and Young Adults Receiving Cancer Treatment

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03709225
Acronym
MAYA
Enrollment
38
Registered
2018-10-17
Start date
2019-01-22
Completion date
2021-04-05
Last updated
2022-11-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety, Oncology, Stress

Keywords

Anxiety, Music Therapy, Oncology, Adolescent and Young Adults

Brief summary

This study is evaluating how well a music therapy program works to improve anxiety and stress in adolescents and young adults receiving cancer treatment.

Detailed description

This research study will test how well a music therapy program works to improve anxiety and stress in adolescents and young adults receiving cancer treatment. The program is designed to incorporate music-based meditation practices and music making activities (e.g., guitar, drums) to help promote relaxation during cancer treatment.

Interventions

BEHAVIORALMusic-based meditation

The program is designed to incorporate music-based meditation practices and music making activities (e.g., guitar, drums) to help promote relaxation during cancer treatment

Sponsors

Dana-Farber Cancer Institute
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
15 Years to 39 Years
Healthy volunteers
No

Inclusion criteria

* Age 15 - 39 years of age * Have a diagnosis of any cancer * Have begun treatment for cancer and plan to receive active cancer treatment (e.g., radiation, chemotherapy, or oral chemotherapy) over the next eight weeks * Signed informed consent/assent * Willingness to participate in all study activities * Speak/read English

Exclusion criteria

* Prognosis \< 3 months, * Self-report inability to physically interact with musical instruments (e.g., hold instruments) * Documentation of significant hearing impairment (e.g., deaf).

Design outcomes

Primary

MeasureTime frameDescription
Number of adolescent and young adults recruited to participate in the music therapy programFrom enrollment to end of treatment at 12 weeksFeasibility of participant recruitment to the music intervention
Frequency of music therapy sessions attended by participantsFrom enrollment to end of treatment at 12 weeksFeasibility of participant adherence to the music intervention
Frequency of outcome assessments completed by participants.From enrollment to end of treatment at 12 weeksFeasibility of participant adherence to outcome assessments

Secondary

MeasureTime frameDescription
Pain Interference: PROMISFrom enrollment to end of treatment at 12 weeksChange in Patient Reported Outcomes Measurement Information System (PROMIS) Pain Interference 4a score from enrollment to the end of treatment at 12 weeks. Total scores range from 41.6 - 75.6, with higher scores representing worse pain interference.
FatigueFrom enrollment to end of treatment at 12 weeksChange in Patient Reported Outcomes Measurement Information System (PROMIS) Fatigue 4a score from enrollment to the end of treatment at 12 weeks. Total scores range from 33.7 - 75.8, with higher scores representing worse fatigue.
Satisfaction with participation in social roles: PROMISFrom enrollment to end of treatment at 12 weeksChange in Patient Reported Outcomes Measurement Information System (PROMIS) Satisfaction with Participation in Social Roles 4a score from enrollment to end of treatment at 12 weeks. Total scores range from 29 - 64.1, with higher scores representing worse satisfaction with participation in social roles.
Acceptability and Satisfaction with Participation in Music Therapy Intervention as measured by the Adapted Acceptability E - Scale.End of treatment at 12 weeksEach item of the Adapted Acceptability E - Scale is scored individually on a 1 - 5 scale, with higher scores representing greater acceptability and satisfaction with the music therapy intervention.
DepressionFrom enrollment to end of treatment at 12 weeksChange in Patient Reported Outcomes Measurement Information System (PROMIS) Depression 4a score from enrollment to the end of treatment at 12 weeks. Total scores range from 41.0 - 79.4, with higher scores representing worse depression.
AnxietyFrom enrollment to end of treatment at 12 weeksChange in Patient Reported Outcomes Measurement Information System (PROMIS) Anxiety 4a score from enrollment to the end of treatment at 12 weeks. Total scores range from 40.3 - 81.6, with higher scores representing worse anxiety.
Physical FunctionFrom enrollment to end of treatment at 12 weeksChange in Patient Reported Outcomes Measurement Information System (PROMIS) Physical Function 4a score from enrollment to the end of treatment at 12 weeks. Total scores range from 22.9 - 56.9, with higher scores representing worse physical function.
Pain Intensity: PROMISFrom enrollment to end of treatment at 12 weeksChange in 0 - 10 numerical rating scale of average pain (included in Patient Reported Outcomes Measurement Information System (PROMIS) - 29 profile)) from enrollment to end of treatment at 12 weeks. Total scores range from 0 - 10, with higher scores representing worse pain.
Post-traumatic growthFrom enrollment to end of treatment at 12 weeksChange in Post Traumatic Growth Inventory - Short Form score from enrollment to the end of treatment at 12 weeks. Total scores on the Post Traumatic Growth Inventory Short Form range from 0 - 50, with higher scores representing greater post-traumatic growth.
StressFrom enrollment to end of treatment at 12 weeksChange in Perceived Stress Scale score from enrollment to the end of treatment at 12 weeks. The scale is scored from 0 - 40, with higher scores representing greater stress.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 23, 2026